Immunization with Multiple Virulence Factors Provides Maternal and Neonatal Protection against Group B Streptococcus Serotypes
Group B streptococcus (GBS) commonly colonizes the vaginal tract and is a leading cause of life-threatening neonatal infections and adverse pregnancy outcomes. No effective vaccine is clinically available. Conserved bacterial virulence factors, including those of GBS, have been employed as vaccine c...
Main Authors: | Jie Wang, Wenbo Li, Ning Li, Beinan Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/11/9/1459 |
Similar Items
-
Group B Streptococcus: Virulence Factors and Pathogenic Mechanism
by: Yuxin Liu, et al.
Published: (2022-12-01) -
Group B Streptococcal Maternal Colonization and Neonatal Disease: Molecular Mechanisms and Preventative Approaches
by: Kathryn A. Patras, et al.
Published: (2018-02-01) -
MATERNAL RISK FACTORS FOR GROUP B STREPTOCOCCUS (GBS) VAGINAL COLONIZATION
by: Hanan H. Wahid, et al.
Published: (2022-06-01) -
Human Milk Oligosaccharides versus Streptococcus: How a Human-Made Natural Product Protects Us from Pathogens
by: Laurie M. Lyon, et al.
Published: (2022-02-01) -
Immunity to Sda1 Protects against Infection by Sda1<sup>+</sup> and Sda1<sup>−</sup> Serotypes of Group A <i>Streptococcus</i>
by: Shuai Bi, et al.
Published: (2022-01-01)